Competing interests
TUMORS
CC, TP, AE, and M-HS are co-inventors of the ShallowHRDv2 method (European Patent Application number EP23170829, filed on April 28th, 2023, and entitled “METHODS FOR DIAGNOSING A HOMOLOGOUS RECOMBINATION DEFICIENCY IN HUMAN TUMORS”). TP and M-HS are co-inventors of the LST method (US20170260588, US20150140122 and exclusive Licensing to Myriad Genetics).